American Remedies Healthcare Private Limited

Pharmaceutical company manufacturing adenocan, ADR, and hypodermic syringes, incorporated in 2020 in Mumbai.

2020 | Thane, Maharashtra (India) | Active
Last Updated: December 28, 2024

American Remedies Healthcare Profile

Key Indicators

  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth 2058.68%
  • Profit Growth 454.20%
  • Ebitda 606.60%
  • Net Worth 320.25%
  • Total Assets 173.90%

About American Remedies Healthcare

American Remedies Healthcare Private Limited (ARHPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 February 2020 (Four years and 11 months 16 days old ). Its registered office is in Thane, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Sanjay Parekh, Bhavesh Jain, and Rinkesh Shah serve as directors at the Company.

Company Details

  • Location

    Thane, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24239MH2020PTC338043

  • Company No.

    338043

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    20 Feb 2020

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

What products or services does American Remedies Healthcare Private Limited offer?

American Remedies Healthcare Private Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Injectable Products, Cardiovascular Drugs & Medication, Cardiac Drugs, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Nutraceuticals, Pain Relief Drugs & Pharmaceuticals, Osteoporosis Medications.

Who are the key members and board of directors at American Remedies Healthcare?

Executive Team (2)

Name Designation Appointment Date Status
Sanjay Parekh Country flag representing In Managing Director 20-Feb-2020 Current
Rinkesh Shah Country flag representing In Managing Director 23-Jul-2020 Current

Board Members (1)

Name Designation Appointment Date Status
Bhavesh Jain Country flag representing In Director 20-Feb-2020 Current

Financial Performance of American Remedies Healthcare.

American Remedies Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 2058.68% increase. The company also saw a substantial improvement in profitability, with a 454.2% increase in profit. The company's net worth Soared by an impressive increase of 320.25%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
2058.68%
Revenue from Operations
2057.67%
Total Assets
173.90%
Profit or Loss
454.20%
Net Worth
320.25%
EBITDA
606.60%

What is the Ownership and Shareholding Structure of American Remedies Healthcare?

In 2022, American Remedies Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at American Remedies Healthcare?

American Remedies Healthcare has a workforce of 19 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of American Remedies Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped American Remedies Healthcare's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on American Remedies Healthcare

Recent activity within the organization

  • Annual General Meeting

    American Remedies Healthcare Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    American Remedies Healthcare Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

    31 Mar 2024

  • Director Appointment

    Rinkesh Chandrakant Shah was appointed as a Managing Director was appointed as a Managing Director on 23 Jul 2020 & has been associated with this company since 4 years 6 months .

    23 Jul 2020

  • Director Appointment

    Sanjay Sampatraj Parekh was appointed as a Managing Director was appointed as a Managing Director on 20 Feb 2020 & has been associated with this company since 4 years 11 months .

    20 Feb 2020

  • Director Appointment

    Bhavesh Prakash Jain was appointed as a Director was appointed as a Director on 20 Feb 2020 & has been associated with this company since 4 years 11 months .

    20 Feb 2020

  • Company Incorporation

    American Remedies Healthcare Private Limited was registered on 20 Feb 2020 with Roc Mumbai & aged 4 years 11 months as per MCA records.

    20 Feb 2020

Frequently asked questions

  • American Remedies Healthcare Private Limited was incorporated on 20 Feb 2020.

  • The authorized share capital of American Remedies Healthcare Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.10 M.

  • Currently 3 directors are associated with American Remedies Healthcare Private Limited.

    • Sanjay Sampatraj Parekh
    • Bhavesh Prakash Jain
    • Rinkesh Chandrakant Shah
  • As per Ministry of Corporate Affairs (Mca), the registered address of American Remedies Healthcare Private Limited is 1442/28 Budgt Gala18 Gr Flr Jai Matadi Compound Kalher, Thane India, Bhiwandi, Maharashtra, 421302.

  • The corporate identification number (CIN) of American Remedies Healthcare Private Limited is U24239MH2020PTC338043 and the company number is 338043 as per Ministry of Corporate Affairs (MCA).

  • The Official website of American Remedies Healthcare Private Limited is https://www.americanremedies.in

  • According to the financial reports for the fiscal year 2022, the revenue trend for American Remedies Healthcare Private Limited has risen by 2058.68%.

  • As Per 2022 financial reports, 19 employees are currently employed by American Remedies Healthcare Private Limited.

  • The financial reports for the fiscal year 2022 indicates that The net worth of American Remedies Healthcare Private Limited has experienced an upsurge of 320.25%.

  • The most recent Balance Sheet for American Remedies Healthcare Private Limited was filed with the ROC on 31 Mar 2024.